×

Bioqual Debt to Equity Ratio 2010-2024 | BIOQ

Current and historical debt to equity ratio values for Bioqual (BIOQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bioqual debt/equity for the three months ending August 31, 2024 was 0.00.
Bioqual Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-08-31 $0.02B $0.04B 0.46
2024-05-31 $0.02B $0.04B 0.50
2024-02-29 $0.02B $0.04B 0.52
2023-11-30 $0.02B $0.04B 0.54
2023-08-31 $0.02B $0.04B 0.60
2023-05-31 $0.02B $0.04B 0.63
2023-02-28 $0.02B $0.04B 0.61
2022-11-30 $0.03B $0.04B 0.62
2022-08-31 $0.03B $0.04B 0.67
2022-05-31 $0.03B $0.04B 0.68
2022-02-28 $0.03B $0.04B 0.73
2021-11-30 $0.03B $0.04B 0.76
2021-08-31 $0.02B $0.04B 0.54
2021-05-31 $0.02B $0.03B 0.59
2021-02-28 $0.02B $0.03B 0.60
2020-11-30 $0.02B $0.03B 0.69
2020-08-31 $0.02B $0.03B 0.69
2020-05-31 $0.02B $0.03B 0.76
2020-02-29 $0.02B $0.03B 0.77
2019-11-30 $0.02B $0.03B 0.83
2019-08-31 $0.00B $0.00B 0.00
2019-05-31 $0.00B $0.03B 0.15
2019-02-28 $0.00B $0.00B 0.00
2018-11-30 $0.00B $0.00B 0.00
2018-08-31 $0.00B 0.00
2018-05-31 $0.00B $0.02B 0.19
2018-02-28 $0.00B 0.00
2017-11-30 $0.00B 0.00
2017-08-31 $0.00B 0.00
2017-05-31 $0.00B 0.00
2017-02-28 $0.00B 0.00
2016-11-30 $0.00B 0.00
2016-08-31 $0.00B 0.00
2016-05-31 $0.00B 0.00
2016-02-29 $0.00B 0.00
2015-11-30 $0.00B 0.00
2015-08-31 $0.00B 0.00
2015-05-31 $0.00B 0.00
2015-02-28 $0.00B 0.00
2014-08-31 $0.00B 0.00
2014-05-31 $0.00B 0.00
2013-11-30 $0.00B 0.00
2013-08-31 $0.00B 0.00
2013-05-31 $0.00B 0.00
2012-05-31 $0.00B 0.00
2012-02-29 $0.00B 0.00
2011-11-30 $0.00B 0.00
2011-08-31 $0.00B 0.00
2011-05-31 $0.00B 0.00
2011-02-28 $0.00B 0.00
2010-11-30 $0.00B 0.00
2010-08-31 $0.00B 0.00
2010-05-31 $0.00B 0.00
2010-02-28 $0.00B 0.00
2009-11-30 $0.00B 0.00
2009-08-31 $0.00B $0.00B 0.00
2009-05-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.058B $0.059B
BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.257B 0.00
Quest Diagnostics (DGX) United States $16.849B 17.08
DaVita (DVA) United States $12.285B 15.89
Encompass Health (EHC) United States $9.254B 21.82
Chemed (CHE) United States $7.946B 24.42
Elanco Animal Health (ELAN) United States $5.957B 14.18
RadNet (RDNT) United States $5.193B 115.00
Option Care Health (OPCH) United States $3.863B 18.31
Amedisys (AMED) United States $2.977B 21.19
LifeStance Health (LFST) United States $2.889B 0.00
Addus HomeCare (ADUS) United States $2.253B 26.44
Astrana Health (ASTH) United States $1.811B 24.77
U.S Physical Therapy (USPH) United States $1.327B 34.87
Pennant (PNTG) United States $0.909B 36.75
Aveanna Healthcare Holdings (AVAH) United States $0.871B 0.00
Atai Life Sciences (ATAI) Germany $0.268B 0.00
Daxor (DXR) United States $0.037B 0.00
Ontrak (OTRK) United States $0.008B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00
Psychemedics (PMD) United States $0.000B 0.00